Home › Therapeutic areas › Oncology › Colorectal Cancer
Colorectal Cancer (27 companies)
Companies with an active program in Colorectal Cancer.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| ADAG | Adagene | Oncology | 1 | Phase 2 | 10 |
| AKTS | Aktis Oncology | Oncology | 1 | Phase 1 | 10 |
| ARVN | Arvinas | NeurologyOncology Rare | 1 | Approved | 12 |
| BCAX | Bicara Therapeutics | Oncology | 1 | Phase 2 | 4 |
| BBOT | BridgeBio Oncology Therapeutics | Oncology | 2 | Phase 1 | 6 |
| CMPX | Compass Therapeutics | Oncology | 1 | Phase 2 | 15 |
| CBIO | Crescent Biopharma | Oncology | 1 | Phase 2 | 10 |
| CYDY | CytoDyn | NeurologyOncology | 1 | Phase 2 | 3 |
| CTMX | CytomX Therapeutics | Oncology | 1 | Phase 1 | 6 |
| ELTX | Elicio Therapeutics | Oncology | 1 | Phase 2 | 6 |
| EXEL | Exelixis | CardiovascularOncology | 1 | Approved | 22 |
| IBRX | ImmunityBio | Infectious DiseaseOncology | 1 | Approved | 16 |
| IMCR | Immunocore | DermatologyInfectious Disease+2 | 1 | Approved | 11 |
| INBX | Inhibrx Biosciences | Oncology | 1 | NDA Submitted | 6 |
| KZIA | Kazia Therapeutics | Oncology Rare | 1 | Phase 2 | 10 |
| KURA | Kura Oncology | MetabolicOncology | 1 | Approved | 12 |
| LEGN | Legend Biotech | Oncology Rare | 1 | Approved | 17 |
| MAIA | MAIA Biotechnology | Oncology | 1 | Phase 3 | 7 |
| INKT | MiNK Therapeutics | ImmunologyOncology+1 Rare | 1 | Phase 2 | 7 |
| ONCY | Oncolytics Biotech | Oncology | 1 | Phase 2 | 3 |
| PMVP | PMV Pharmaceuticals | Oncology | 1 | Phase 2 | 7 |
| RVMD | Revolution Medicines | Oncology | 1 | Approved | 10 |
| SMMT | Summit Therapeutics | Oncology | 1 | NDA Submitted | 5 |
| SNDX | Syndax Pharmaceuticals | ImmunologyOncology+1 Rare | 1 | Approved | 8 |
| VSTM | Verastem | Oncology | 1 | Approved | 5 |
| VIR | Vir Biotechnology | Infectious DiseaseOncology Rare | 2 | Phase 3 | 10 |
| XNCR | Xencor | HematologyImmunology+4 Rare | 1 | Approved | 36 |
No companies match.